sales@angenesci.com
Login | Register
logo
Structures Search
Home Halogens 1,2-Benzisoxazol-3(2H)-one, 5-chloro-

1,2-Benzisoxazol-3(2H)-one, 5-chloro-

CAS No.:
24603-63-2
Catalog Number:
AG002OQL
Molecular Formula:
C7H4ClNO2
Molecular Weight:
169.5652
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG002OQL
Chemical Name:
1,2-Benzisoxazol-3(2H)-one, 5-chloro-
CAS Number:
24603-63-2
Molecular Formula:
C7H4ClNO2
Molecular Weight:
169.5652
MDL Number:
MFCD00125031
IUPAC Name:
5-chloro-1,2-benzoxazol-3-one
InChI:
InChI=1S/C7H4ClNO2/c8-4-1-2-6-5(3-4)7(10)9-11-6/h1-3H,(H,9,10)
InChI Key:
WIZWHBRFTCYPDN-UHFFFAOYSA-N
SMILES:
Clc1ccc2c(c1)c(=O)[nH]o2
Properties
Complexity:
185  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
168.993g/mol
Formal Charge:
0
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
169.564g/mol
Monoisotopic Mass:
168.993g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
38.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.8  
Literature
Title Journal
Pharmacokinetics of oral D-serine in D-amino acid oxidase knockout mice. Drug metabolism and disposition: the biological fate of chemicals 20121101
Contributions of spinal D-amino acid oxidase to bone cancer pain. Amino acids 20121101
Interactions of the potent D-amino acid oxidase inhibitor CBIO with morphine in pain and tolerance to analgesia. Neuropharmacology 20120901
D-Amino acid oxidase-mediated increase in spinal hydrogen peroxide is mainly responsible for formalin-induced tonic pain. British journal of pharmacology 20120301
A series of D-amino acid oxidase inhibitors specifically prevents and reverses formalin-induced tonic pain in rats. The Journal of pharmacology and experimental therapeutics 20110101
Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia. Dialogues in clinical neuroscience 20100901
Commentary: genome-based CNS drug discovery: D-amino acid oxidase (DAAO) as a novel target for antipsychotic medications: progress and challenges. Biochemical pharmacology 20091201
Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine. Biological psychiatry 20090615
Synthesis and biological evaluation of D-amino acid oxidase inhibitors. Journal of medicinal chemistry 20080626
Properties